What it is
Semaglutide is a GLP-1 receptor agonist and a peptide-based active ingredient. Health Canada has authorized specific prescription drug products containing semaglutide for specific uses.
Why the finished product matters
An authorized product has a specific manufacturer, formulation, strength, route, label, DIN, and product monograph. That authorization does not cover a vial from an unrelated online seller, a custom mixture, a different route, or a claim outside the regulator-reviewed label.
Canadian context
Search the Drug Product Database using the ingredient name, then match the exact DIN and product details. Health Canada has also seized unauthorized products labelled semaglutide, showing why an ingredient name alone is not enough.
Evidence and safety
Large human clinical programs support the authorized uses of specific semaglutide products. Benefits, contraindications, warnings, and adverse effects should be read in the applicable Canadian product monograph and discussed with a licensed prescriber or pharmacist. This library does not provide product selection or personal treatment advice.
Source trail